- 1900
Researchers from Turku Bioscience Centre Identified Novel Oncogenic Function for Receptor Linked with Alzheimer’s Disease
28 May, 2019
Common and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer’s disease. So far, SORLA has been mainly studied in neurons, but the new study focused on the role of SORLA in cancer cells. Led by Academy Professor Johanna Ivaska, the research group observed that SORLA was highly expressed in HER2 positive cancers. Removing SORLA from cancer cells severely impaired the oncogenic fitness of HER2 positive cancers.
- 1900
- 1900
Inspiring and thoughtful discussion on cancer
28 Apr, 2019
Academy Professor Johanna Ivaska was invited to the popular talk-show Flinkkilä & Tastula to discuss cancer research together with the stand-up comedian Anitta Ahonen, who was diagnosed with cancer three years ago.
- 1900
The new name of Turku Bioscience and its 30 year anniversary gets wide publicity
25 Apr, 2019
The anniversary of Turku Bioscience and its anniversary was highlighted in all local media yesterday and today.
- 1900
Four new Academy of Finland postdoctoral researcher positions to Turku Bioscience
23 Apr, 2019
Turku Bioscience proudly presents four new post doctoral fellows
- 1905
Laura Elo Receives the Rising Talent Award of the For Women in Science Programme
8 Mar, 2019
Research Director Laura Elo from Turku Centre for Biotechnology receives the international Rising Talent Award of the For Women in Science programme granted by the L’Oréal Foundation and UNESCO. The recognition is awarded to 15 most promising women researchers from all over the world. The recognition is awarded on Thursday, 14 March in Paris.
- 1900
Researchers Discovered New Immune Response Regulators
15 Jan, 2019
The research groups of Academy Professor Riitta Lahesmaa and Research Director Laura Elo from Turku Centre for Biotechnology have discovered new proteins that regulate T cells in the human immune system. Some of these proteins can provide possible new targets for drug development in treating immune-mediated diseases.
- 1900
- 1900
Finnish Medical Foundation awarded €150,000 to CBT´s affiliated group leader Sami Ventelä
22 Nov, 2018
Finnish Medical Foundation awarded Research Group Founder Grant of €150,000 to Clinical Lecturer at the University of Turku, Specialist in Otorhinolaryngology, MD Sami Ventelä. Ventelä is also a new Affiliated Group Leader at Turku Centre for Biotechnology.
- 1900
Syöpäsolujen hoitovastetta määrittävän jarrumekanismin tutkimukselle Syöpäsäätiön suurapuraha (In Finnish only)
14 Nov, 2018
Syöpäsäätiö on myöntänyt 450 000 euron suurapurahan Turun yliopiston kolmevuotiselle tutkimushankkeelle, jonka tavoitteena on selvittää syöpäsolun sisäisiä mekanismeja rintasyövässä ja pahanlaatuisessa aivosyövässä.
- 1900
New Mathematical Model Predicts Respiratory Viral Infection Symptoms Severity
5 Nov, 2018
A team from the University of Turku has developed a mathematical model that predicts which patients become symptomatic after viral exposure using gene expression levels in blood prior to exposure.
- 1900
- 1900
- 1900
News and Events
No menu selected
